Tech Company Financing Transactions
Surface Logix Funding Round
Surface Logix secured a $20 million Series D venture capital round on 4/4/2007. Investors included Arch Venture Partners, HBM Healthcare Investments and Unilever.
Transaction Overview
Company Name
Announced On
4/4/2007
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series D
Investors
Proceeds Purpose
Proceeds purposes will be to further clinical development.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
50 Soldiers Field Place
Brighton, MA 02135
USA
Brighton, MA 02135
USA
Phone
Website
Email Address
Overview
Surface Logix is a drug development company which uses its expertise in biophysical chemistry to create new small molecule drugs with significantly improved pharmacokinetic (PK) and pharmacodynamic (PD) properties compared with class leaders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Keith Dionne
Chief Scientific Officer
Paul Sweetnam
Vice President
John Ferkany
Vice President
Enoch Kim
Vice President
Bridget McCarthy
Vice President
Olivier Schueller
Vice President
Warwick Tong
VP - General Counsel
Winston Henderson
Browse more venture capital transactions:
Prev: 4/4/2007: SustainLane venture capital transaction
Next: 4/4/2007: Firm58 venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs